Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 5162 [E9-1867]
Download as PDF
<![CDATA[
5162
Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices
Dr. Nyugen has entered into a
Voluntary Settlement Agreement with
ORI. As part of that Agreement, Dr.
Nyugen admits to UCLA’s findings of
fact but denies ORI’s findings that the
actions rise to the level of scientific
misconduct. The settlement is not an
admission of liability on the part of the
Respondent. Dr. Nyugen voluntarily
agreed, for a period of three (3) years,
beginning on December 29, 2008:
(1) Not to serve in any advisory
capacity to PHS, including but not
limited to service on any PHS advisory
committee, board, and/or peer review
committee, or as a consultant; and
(2) That although Respondent is not
currently engaged in PHS–supported
research, any institution that submits an
application for PHS support for a
research project on which the
Respondent’s participation is proposed
or that uses the Respondent in any
capacity on PHS supported research, or
that submits a report of PHS-funded
research in which the Respondent is
involved, must concurrently submit a
plan for supervision of the Respondent(s
duties to the funding agency for
approval. The supervisory plan must be
designed to ensure the scientific
integrity of the Respondent(s research
contribution. Respondent agreed to
ensure that a copy of the supervisory
plan also is submitted to ORI by the
institution for ORI approval.
Respondent agreed to not participate in
any PHS-supported research until such
a supervisory plan is submitted to ORI.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E9–1933 Filed 1–28–09; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
rmajette on PRODPC74 with NOTICES
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the eighteenth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
10 a.m. to approximately 5:30 p.m. on
Thursday, March 12, 2009, and 8:30
a.m. to approximately 3 p.m. on Friday,
March 13, 2009, at the Hubert H.
VerDate Nov<24>2008
15:25 Jan 28, 2009
Jkt 217001
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
The meeting will be open to the public
with attendance limited to space
available. The meeting also will be Web
cast.
At this meeting, the Committee will
begin to explore issues related to
genetics and the future of the health
care system with the first in a series of
roundtables focusing on perspectives of
stakeholders in the payer community.
Other agenda items include a session on
developments related to informed
consent for genomic data sharing,
discussion of the Committee’s next steps
to address concerns related to
consumer-initiated genomic services,
and updates on Department of Health
and Human Services and agency
priorities.
As always, the Committee welcomes
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment should notify the SACGHS
Executive Secretary, Ms. Sarah Carr, by
telephone at 301–496–9838 or e-mail at
carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892. Anyone
planning to attend the meeting, who is
in need of special assistance, such as
sign language interpretation or other
reasonable accommodations, is also
asked to contact the Executive
Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
oba.od.nih.gov/SACGHS/
sacghs_home.html.
Dated: January 22, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory
Committee Policy.
[FR Doc. E9–1867 Filed 1–28–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Assessing Organizational Responses to
AHRQ’s Health Literacy Pharmacy
Tools.’’ In accordance with the
Paperwork Reduction Act of 1995, 44
U.S.C. 3506(c)(2)(A), AHRQ invitesthe
public to comment on this proposed
information collection.
DATES: Comments on this notice must be
received by March 30, 2009.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports clearance Officer, AHRQ, by email at doris.lefkowitz@ahrq.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at doris.leflowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project: Assessing
Organizational Responses to AHRQ’s
Health Literacy Pharmacy Tools
According to the 2003 National
Assessment of Adult Literacy, only 12
percent of adults have proficient health
literacy-the capacity to obtain, process,
and understand basic health
information and services needed to
make appropriate health decisions.
Limited health literacy often leads to
medication errors. For example, one
study found that a majority of adults
with low health literacy did not
understand instructions to ‘‘take
medication on an empty stomach.’’
Overall, it is estimated that low health
literacy costs the U.S. health care
system $50 billion to $73 billion per
year. Pharmacies can serve as an
important source of medication
information for people with limited
health literacy, but relatively few
pharmacies have implemented health
literacy practices (Praska et al., 2005).
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 74, Number 18 (Thursday, January 29, 2009)]
[Notices]
[Page 5162]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-1867]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
eighteenth meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from 10 a.m. to approximately 5:30 p.m. on Thursday, March
12, 2009, and 8:30 a.m. to approximately 3 p.m. on Friday, March 13,
2009, at the Hubert H. Humphrey Building, 200 Independence Avenue, SW.,
Washington, DC 20201. The meeting will be open to the public with
attendance limited to space available. The meeting also will be Web
cast.
At this meeting, the Committee will begin to explore issues related
to genetics and the future of the health care system with the first in
a series of roundtables focusing on perspectives of stakeholders in the
payer community. Other agenda items include a session on developments
related to informed consent for genomic data sharing, discussion of the
Committee's next steps to address concerns related to consumer-
initiated genomic services, and updates on Department of Health and
Human Services and agency priorities.
As always, the Committee welcomes hearing from anyone wishing to
provide public comment on any issue related to genetics, health and
society. Individuals who would like to provide public comment should
notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at
301-496-9838 or e-mail at carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone
planning to attend the meeting, who is in need of special assistance,
such as sign language interpretation or other reasonable
accommodations, is also asked to contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://
oba.od.nih.gov/SACGHS/sacghs_home.html.
Dated: January 22, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. E9-1867 Filed 1-28-09; 8:45 am]
BILLING CODE 4140-01-P
